Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Vismodegib for periocular and orbital basal cell carcinoma
Harmeet S Gill1, Eve E Moscato2, Anne Lynn S Chang3
1Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
Vismodegib showed effectiveness in treating periocular and orbital basal cell carcinoma (BCC), with about half of patients achieving significant tumor reduction. Close monitoring for adverse effects and new skin cancers is recommended.
Area of Science:
- Ophthalmology
- Dermatology
- Oncology
Background:
- Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, often locally invasive.
- Untreated BCC can cause significant destruction to periocular and orbital tissues.
Purpose of the Study:
- To evaluate the efficacy and tolerability of vismodegib for treating periocular and orbital BCC.
- To assess the feasibility of vismodegib as a treatment option for advanced eyelid tumors.
Main Methods:
- Prospective observational case series of 7 patients with advanced periocular/orbital BCC.
- Patients received oral vismodegib (150 mg daily) until maximal response or intolerance.
- Lesion size reduction and adverse effects were primary endpoints.
Main Results:
- All 7 patients had locally advanced, recurrent BCC unsuitable for surgery or radiation.
- Complete or significant partial regression (>80%) observed in 57% of patients.
- Common adverse reactions included alopecia, dysgeusia, and muscle cramps; 29% developed new squamous cell carcinomas.
Conclusions:
- Vismodegib demonstrates potential efficacy and tolerability for periocular and orbital BCC.
- Approximately half of the treated patients experienced substantial tumor regression.
- Vigilant monitoring for secondary malignancies at uninvolved sites is crucial during vismodegib therapy.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems
Diabetic Retinopathy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...

